Swedish Orphan Biovit Ord (BIOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 72,759 | 50,645 | 85,247 | 62,715 | 75,050 |
| Receivables | 657,256 | 770,338 | 544,205 | 593,943 | 565,630 |
| Inventories | 348,475 | 342,500 | 365,318 | 363,340 | 386,935 |
| Other current assets | -94 | 0 | 0 | -93 | 0 |
| TOTAL | $1,078,396 | $1,163,483 | $1,194,875 | $1,019,905 | $1,027,615 |
| Non-Current Assets | |||||
| PPE Net | 23,630 | 24,698 | 23,669 | 24,420 | 29,165 |
| Investments And Advances | 17,092 | 18,643 | 13,391 | 14,615 | 12,160 |
| Intangibles | 5,625,015 | 5,874,881 | 5,669,316 | 5,856,822 | 6,048,935 |
| Other Non-Current Assets | 89,758 | 79,379 | 79,589 | 74,556 | 81,415 |
| TOTAL | $5,755,495 | $5,997,601 | $5,785,965 | $5,970,413 | $6,171,675 |
| Total Assets | $6,833,891 | $7,161,180 | $6,980,746 | $6,990,317 | $7,199,385 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 555,076 | 720,654 | 831,066 | 300,533 | 1,001,490 |
| Accounts payable and accrued liabilities | 98,537 | 64,483 | 96,563 | 97,588 | 88,635 |
| Accrued Expenses | N/A | N/A | 494,886 | N/A | N/A |
| Other current liabilities | 818,744 | 844,719 | 357,208 | 853,590 | 642,105 |
| TOTAL | $1,484,313 | $1,643,791 | $1,800,658 | $1,264,568 | $1,746,765 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,014,698 | 1,095,828 | 1,070,871 | 1,619,305 | 1,641,695 |
| Other Non-Current Liabilities | 299,440 | 309,442 | 285,635 | 230,140 | 399,760 |
| TOTAL | $1,954,395 | $2,067,111 | $1,986,430 | $2,540,790 | $2,756,900 |
| Total Liabilities | $3,438,708 | $3,710,902 | $3,787,088 | $3,805,265 | $4,503,665 |
| Shareholders' Equity | |||||
| Common Shares | 18,120 | 18,643 | 18,294 | 17,945 | 16,245 |
| Retained earnings | 1,780,484 | 1,810,428 | 1,702,587 | 1,604,228 | 1,638,560 |
| Other shareholders' equity | 17,372 | 26,716 | -88,077 | 73,629 | 82,365 |
| TOTAL | $3,395,183 | $3,450,278 | $3,193,658 | $3,185,052 | $2,695,625 |
| Total Liabilities And Equity | $6,833,891 | $7,161,180 | $6,980,746 | $6,990,317 | $7,199,290 |